These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5271986)

  • 21. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of clinical trials of a new antitubercular agent, terizidone (Terivalidine)].
    Zrilić V; Mijatović M; Mirković S; Muzikravić T
    Plucne Bolesti Tuberk; 1972; 24(2):89-98. PubMed ID: 4565191
    [No Abstract]   [Full Text] [Related]  

  • 23. [Unmotivated suicide as a most serious complication in the treatment of pulmonary tuberculosis using D-cycloserine].
    Schumann C
    Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):295-302. PubMed ID: 5756628
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 25. [Terisidon in chemotherapy of pulmonary tuberculosis].
    Kolosovskaia VP; Korotaev GA
    Probl Tuberk; 1974; (12):15-8. PubMed ID: 4445129
    [No Abstract]   [Full Text] [Related]  

  • 26. [The therapy of pulmonary tuberculosis in psychopathic patients, using terizidone].
    Micheletti V; Teti V; Fenzi P; Usberti G
    Minerva Med; 1968 May; 59(42):2459-65. PubMed ID: 5653337
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract]   [Full Text] [Related]  

  • 28. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)].
    Rizzo A; Magalhães M; Moura N
    Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888
    [No Abstract]   [Full Text] [Related]  

  • 29. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
    Wagner J
    Gruzlica; 1966 Mar; 34(3):249-54. PubMed ID: 5947778
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suicide of two patients during the postoperative course after pulmonary resection: possible effect of cycloserine.
    Esteves Pinto E
    Scand J Respir Dis Suppl; 1970; 71():256-8. PubMed ID: 5271997
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of cycloserine on the human body].
    Rózewska M; Gajewska E; Graczyk J
    Gruzlica; 1969 Jun; 37(6):523-8. PubMed ID: 5350917
    [No Abstract]   [Full Text] [Related]  

  • 33. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cycloserine and terizidone in the treatment of pulmonary tuberculosis: clinical study of tolerance].
    Rizzo A; Gomes A; Antunes G
    Rev Bras Med; 1969 Feb; 26(2):119-22. PubMed ID: 5797682
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacokinetics of cycloserine and ethambutol].
    Zitkova L; Toushek I
    Probl Tuberk; 1978 Mar; (3):23-5. PubMed ID: 652762
    [No Abstract]   [Full Text] [Related]  

  • 37. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical tolerance to cycloserine.
    Stephanopoulos C; Zoumbouloglou H
    Scand J Respir Dis Suppl; 1970; 71():235-8. PubMed ID: 5271993
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical problems of the syntropy of pulmonary tuberculosis and stomach resection].
    Kühn RA; Kob D; Meisl B
    Z Gesamte Inn Med; 1971 Apr; 26(8):265-8. PubMed ID: 5565822
    [No Abstract]   [Full Text] [Related]  

  • 40. Considerations on ten years' use of cycloserine.
    Sanguigno N
    Scand J Respir Dis Suppl; 1970; 71():178-9. PubMed ID: 5271982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.